Drugs / Cosiporfin
Cosiporfin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07398339 | Mar 2026 → Mar 2027 expected | biliary tract cancer | Shanghai Guangsheng Biopharmaceutical Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cosiporfin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07398339 ↗ |
| Known as | Cosiporfin Sodium | “Cosiporfin Sodium for injection, DVDMS” NCT07398339 ↗ |
| Known as | DVDMS | “Cosiporfin Sodium for injection, DVDMS” NCT07398339 ↗ |